免疫细胞因子和细胞因子中和用于癌症免疫疗法
Pedro Berraondo1, Raquel Cuesta2, Fernando Aranda2
1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
Trends in cancer
|May 27, 2025
概括
增强癌症免疫疗法包括向的细胞因子输送和阻断促进瘤的因素. 将这些策略与现有治疗方法相结合,为患者提供了更好的疗效和减少副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 基于细胞因子的免疫疗法由于治疗窗口狭窄和疗效问题,其临床影响有限.
- 局部输送和针对性细胞因子与抗体 (免疫细胞因子) 融合提供了增强治疗的机会.
- 中和前瘤细胞因子可以改善传统免疫疗法并减少副作用.
研究的目的:
- 探索增强癌症免疫疗法的疗效和减轻副作用的策略.
- 研究向性细胞因子输送和细胞因子中和在癌症治疗中的潜力.
- 评估结合免疫细胞因子和细胞因子抗剂与其他疗法的协同作用潜力.
主要方法:
- 免疫细胞因子的开发,以有针对性地提供抗瘤细胞因子.
- 利用抗体,细胞因子陷或受体对抗剂来中和前瘤细胞因子.
- 研究介质蛋白 (IL) -2,IL-12,IL-15,IL-18和IL-21与其他治疗方法的协同作用组合.
- 探索转化生长因子-β,瘤亡因子,IL-1,IL-6,CXCR1/2化学因子和生长分化因子15的对抗性中和.
主要成果:
- 免疫细胞因子提供一种方法,用于局部传递和向抗瘤细胞因子到瘤组织.
- 对前瘤细胞因子的中和可以增强检查点抑制剂的疗效,并减少相关的副作用.
- 特定互白蛋白 (IL-2,IL-12,IL-15,IL-18,IL-21) 的协同作用组合显示出有前途.
- 在组合策略中,对特定细胞因子和化学因子的对抗性中和似乎是有益的.
结论:
- 向输送细胞因子和免疫抑制因子的中和是改善癌症免疫疗法的有希望的策略.
- 组合方法,包括免疫细胞因子和细胞因子对抗剂,具有显著的潜力,可以提高疗效和降低毒性.
- 对关键细胞因子的免疫生物学及其向调节的进一步研究是有必要的,以推进癌症治疗.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Cancer Vaccines
522
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
522
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


